Artisan Partners Limited Partnership 13D and 13G filings for Halozyme Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-12 09:36 am Sale | 2024-09-30 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 3,133,412 2.500% | -3,555,646![]() (-53.16%) | Filing |
2024-02-12 06:19 am Sale | 2023-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 6,689,058 5.100% | -451,895![]() (-6.33%) | Filing |
2023-02-10 09:00 am Sale | 2022-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 7,140,953 5.300% | -2,364,815![]() (-24.88%) | Filing |
2022-02-04 06:15 am Sale | 2021-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 9,505,768 6.800% | -778,368![]() (-7.57%) | Filing |
2021-02-10 06:17 am Sale | 2020-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 10,284,136 7.600% | -4,145,901![]() (-28.73%) | Filing |
2020-04-09 09:42 am Purchase | 2020-03-31 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 14,430,037 10.500% | 14,430,037![]() (New Position) | Filing |